Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MEMANTINE HYDROCHLORIDE
- A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.
- Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity
- Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors
- Nabilone for Agitation in Frontotemporal Dementia
- Glutamate Inhibitors in Glioblastoma
- Masitinib in Patients With Mild to Moderate Alzheimer's Disease
- Aripiprazole in Body Focused Repetitive Behaviors
- Efficacy of Chinese Traditional Medicine "Smart Soup" in Cognition and Behavior Regulation in Alzheimer's Disease
- Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain Injury
- Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease
- Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
- The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease
- The Use of Memantine for Prevention of Alzheimer's Disease
- Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique
- Memantine for Refractory OCD Patients
- NTS-WBRT VS HA-WBRT in Brain Metastases
- Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)
- A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
- Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
- Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
- Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases
- Memantine in Body Focused Repetitive Behaviors
- Add-on MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis
- The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy
- Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.
- Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction
- Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radio
- Pragmatic Trial of Obsessive-compulsive Disorder
- Bryostatin Treatment of Moderately Severe Alzheimer's Disease
- Effect of Memantine on Cognitive Impairment in Patients With Epilepsy
- Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
- Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke Aphasia
- Monitoring Anti-Dementia Drugs by Serum Levels
- add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients
- Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
- A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other
- Local Study of Akatinol Memantine in VaD in Russia
- Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
- Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine
- Memantine for Epileptic Encephalopathy
- Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
- Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder
- Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults
- Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
- Memantine and Post-mastectomy Neuropathic Pain
- Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions
- A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
- Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions
- Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases
- Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
- Ketamine for Treatment of MS Fatigue
- Study Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy Subjects
- Effect of Memantine on Radiotherapy-related Cognitive Impairment
- A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
- A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD
- Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
- Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects
- Memantine in Bipolar Patients With Alcoholism
- Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
- Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
- Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy
- A Study of Oxidative Pathways in MS Fatigue
- Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
- 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension
- Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
- SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
- Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
- Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome
- Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome
- Treatment of Pendular Nystagmus in OPT
- Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
- Pharmacovigilance in Gerontopsychiatric Patients
- Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
- Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine Treatment
- Down Syndrome Memantine Follow-up Study
- Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
- An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder
- Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
- Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury
- Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia
- Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects
- Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
- Memantine for Enhanced Stroke Recovery
- Impact of Persistent Conductances on Motor Unit Firing in SCI
- Therapy in Amyotrophic Lateral Sclerosis (TAME)
- Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease
- Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
- A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy Adults
- Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia
- Open-label Study of Safety and Tolerability of Memantine in Children With Autism
- Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder
- The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease
- Brain Aging and Treatment Response in Geriatric Depression
- Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment
- Masitinib in Patients With Mild to Moderate Alzheimer's Disease
- Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease
- Memantine Monotherapy for Executive Dysfunction and ADHD
- Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis
- A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
- Combination Treatment Study for Memory Impairment and Depression
- Attenuation of Corticosteroid Induced Hippocampal Changes
- Randomised Controlled Trial of Memantine in Fibromyalgia
- Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
- Study of NMDA Antagonists and Neuropathic Pain
- Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
- An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
- Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
- Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
- Functional Neuroimaging of Alcoholism Vulnerability (PIT)
- Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
- Prophylaxis of Neuropathic Pain by mémantine
- Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
- Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
- Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
- Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers
- A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease
- Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
- A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease
- Alzheimer's Disease - Input of Vitamin D With mEmantine Assay
- Treatment Resistant Geriatric Depression in Primary Care
- A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
- Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
- Ketamine Infusion for Obsessive-Compulsive Disorder
- Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
- A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
- Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
- Memantine for Recurrent Glioblastoma
- A Study of the Effect of Memantine on Pharmacokinetics, Safety and Tolerability of Single Dose RO5313534 in Healthy Volunteers, and the Effect of RO5313534 on Safety and Tolerability of Steady State Memantine
- Psychopharmacotherapy in Multiple Substances Abuse
- Add-On Therapy to Risperidonein Schizophrenia
- Series Studies of Bipolar Disorder-Valproate add-on Memantine
- Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.
- Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
- Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
- Memantine in Adult Autism Spectrum Disorder
- Study on Cognitive Disorders of Multiple Sclerosis
- Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
- Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?
- Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
- Memantine for Post-Operative Pain Control
- An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
- Memantine and Postoperative Pain
- Exelon Patch and Combination With Memantine Comparative Trial
- Memantine Therapy in Amyotrophic Lateral Sclerosis
- The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?
- Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy
- The Influence of Glutamate on Memory in Humans
- Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder
- Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
- Cross-over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus
- A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
- Memantine in the Treatment of Kleptomania
- Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
- Donepezil and Memantine in Moderate to Severe Alzheimer's Disease
- A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
- Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
- Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
- Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies
- Memantine Treatment of Compulsive Buying
- Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
- Memantine and Validation of a New Alzheimer's Disease Scale
- Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease
- Corticolimbic Degeneration and Treatment of Dementia
- Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms
- Memantine on Aggression and Agitation of Alzheimer's Disease (AD)
- Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
- Study of Memantine to Treat Huntington's Disease
- Memantine and Antipsychotics Use
- Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease
- Memantine and Cognitive Dysfunction in Bipolar Disorder
- Memantine and Intensive Speech-Language Therapy in Aphasia
- Memantine Therapy for Multiple Sclerosis
- Memantine for Spasticity in MS Patients
- Family History Study of Alcohol Consumption Using Memantine
- Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
- Memantine - Communication Study
- Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
- A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis
- Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS
- Memantine and Cognitive Dysfunction in Bipolar Disorder
- Memantine Treatment Study of Pathological Gambling
- Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
- Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS
- Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
- Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
- Memantine Versus Donepezil in Early Stages of Alzheimer's Disease
- Memantine as a Supplement to Naltrexone in Treating Heroin Dependence
- Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
- Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease
- Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury
- A Pilot Clinical Trial Of Memantine for Essential Tremor
- A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
- The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)
- Memantine for Agitation and Aggression in Severe Alzheimer's Disease
- Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease
- Parkinson's Disease Evaluated by PET and the Effect of Memantine
- Memantine for Agitation in Dementia
- Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.
- Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)
- Memantine Augmentation of Antidepressants
- Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
- An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder
- A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
- Prophylactic Effect of Memantine in Chronic Tension-Type Headache
- Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
- Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression
- Namenda to Prevent Post-Operative Delirium
- Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
- Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia
- Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes
- Memantine for Corticosteroid-Induced Mood and Declarative Memory Changes
- Memantine Augmentation in Obsessive-Compulsive Disorder
- Treatment of Orthostatic Intolerance
- The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
- A Placebo-Controlled Trial of Memantine for Alcohol Dependence
- Treatment With Namenda in Women at Risk for Cognitive Decline
- Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome
- Memantine and Down's Syndrome
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
- Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
- Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
- Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled Trial
- A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
- Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression
- Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
- Memantine in Systemic Lupus Erythematosus
- Memantine in Patients With Chronic Glaucoma
- Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease
- Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia
- Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia
- Memantine in Patients With Chronic Glaucoma
- Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3
- The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1
- Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
- Memantine and Naltrexone Treatment for Opioid Dependence
- Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
- An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
- Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
- An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
- Clinical Trial of Memantine for Major Depression
- Dextromethorphan Versus Placebo for Neuropathic Pain
- A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
Clinical trials list
click for details